Work

Rusfertide for Polycythemia Vera: Similar Dosing in Patients Receiving Therapeutic Phlebotomy Alone or in Combination with Cytoreductive Treatment

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-163847

Authors: Aaron T. Gerds, Jason Gotlib, Jeanne M. Palmer, Naveen Pemmaraju, Prithviraj Bose, Yelena Ginzburg, Frank Valone, Nishit B. Modi, Sarita Khanna, Paula G. O'Connor, Suneel K. Gupta, Ronald Hoffman

Institutions: Cleveland Clinic, Stanford Cancer Institute, Stanford University, Mayo Clinic Hospital, The University of Texas MD Anderson Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Protagonist Therapeutics (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310161044

FWCI: 0.621

Cites:

Cited by: 5

Related to: 10